Clarius Group LLC Trims Stock Holdings in CME Group Inc (NASDAQ:CME)

Clarius Group LLC lowered its position in CME Group Inc (NASDAQ:CME) by 3.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,556 shares of the financial services provider’s stock after selling 87 shares during the quarter. Clarius Group LLC’s holdings in CME Group were worth $415,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Alliancebernstein L.P. lifted its stake in CME Group by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 1,582,495 shares of the financial services provider’s stock valued at $317,638,000 after buying an additional 8,234 shares during the last quarter. OLD Dominion Capital Management Inc. lifted its stake in CME Group by 88.9% in the first quarter. OLD Dominion Capital Management Inc. now owns 55,243 shares of the financial services provider’s stock valued at $9,552,000 after buying an additional 26,005 shares during the last quarter. Two Sigma Advisers LP purchased a new stake in CME Group in the first quarter valued at approximately $14,438,000. First Allied Advisory Services Inc. lifted its stake in CME Group by 32.9% in the first quarter. First Allied Advisory Services Inc. now owns 3,435 shares of the financial services provider’s stock valued at $594,000 after buying an additional 850 shares during the last quarter. Finally, Advisor Group Holdings Inc. purchased a new stake in CME Group in the first quarter valued at approximately $8,147,000. Institutional investors own 84.93% of the company’s stock.

Shares of CME stock opened at $168.08 on Thursday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $59.39 billion, a PE ratio of 25.24, a P/E/G ratio of 4.26 and a beta of 0.30. CME Group Inc has a 1-year low of $131.80 and a 1-year high of $225.36. The business’s fifty day moving average price is $176.29 and its 200 day moving average price is $189.82.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 29th. The financial services provider reported $2.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.23 by $0.10. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 10.15% and a net margin of 45.79%. CME Group’s revenue was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.62 earnings per share. Equities research analysts expect that CME Group Inc will post 7.39 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th were issued a $0.85 dividend. This represents a $3.40 annualized dividend and a yield of 2.02%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is 50.00%.

In other news, Director Timothy S. Bitsberger sold 600 shares of the company’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $191.32, for a total value of $114,792.00. Following the sale, the director now directly owns 9,927 shares in the company, valued at $1,899,233.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 1,229 shares of CME Group stock in a transaction dated Thursday, June 11th. The stock was bought at an average price of $178.10 per share, for a total transaction of $218,884.90. Following the completion of the transaction, the director now directly owns 2,000 shares of the company’s stock, valued at $356,200. The disclosure for this purchase can be found here. 1.20% of the stock is currently owned by corporate insiders.

CME has been the topic of a number of recent research reports. Goldman Sachs Group dropped their target price on CME Group from $175.00 to $170.00 and set a “neutral” rating on the stock in a report on Monday, June 22nd. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a report on Thursday, June 25th. Bank of America dropped their target price on CME Group from $216.00 to $168.00 and set a “neutral” rating on the stock in a report on Monday, March 23rd. Cfra dropped their target price on CME Group from $218.00 to $205.00 and set a “hold” rating on the stock in a report on Wednesday, April 29th. Finally, Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $182.00 target price on the stock in a report on Monday, April 6th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $190.81.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: Holder of Record

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.